Prognostic Value of Body Mass Index in Korean Patients With Renal Cell Carcinoma
Authors:
- 1 February 2010
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 183 (2) , 448-454
Abstract
Whether body mass index is a prognostic factor in patients with renal cell carcinoma continues to be debated. We investigated the association between body mass index, and clinical/pathological features and prognosis in a large cohort of Korean patients with renal cell carcinoma. The medical records of 1,017 patients with renal cell carcinoma who underwent curative surgery between 1988 and 2006 were reviewed. Mean followup was 76.9 months. We analyzed the association of body mass index at surgery with tumor pathological features, and its associations with cancer specific survival and overall survival were evaluated using the Kaplan-Meier method and Cox regression models. Additional survival analysis was performed in a subgroup of 897 patients with T1-4N0M0 disease. Of the 1,017 patients 363 (35.7%), 526 (51.7%) and 128 (12.6%) had a body mass index of less than 23 (normal), 23 to 27.5 (overweight) and 27.5 or greater (obese) kg/m(2), respectively. Overweight and obese patients had less aggressive tumors, such as less lymph node and/or distant metastases (p = 0.001), low pathological T stage (p = 0.047) and low Fuhrman grade (p = 0.033) vs normal weight patients. In terms of cancer specific survival and overall survival multivariate analysis showed that overweight (p = 0.040 and p = 0.047, respectively) and obese (p = 0.024 and p = 0.010, respectively) patients had good survival rates compared to those with a body mass index in the normal range in the cohort (T1-4NallMall) groups. In addition, overweight (p = 0.022 and p = 0.029, respectively) and obese (p = 0.009 and p = 0.002, respectively) status was significantly associated with cancer specific and overall survival in the T1-4N0M0 groups. Our findings suggest that overweight and obese Korean patients with renal cell carcinoma have more favorable pathological features and a better prognosis than those with a normal body mass index.Keywords
This publication has 15 references indexed in Scilit:
- Racial/Ethnic and Gender Disparities in Renal Cell Carcinoma Incidence and SurvivalJournal of Urology, 2008
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Cancer Incidence, Mortality, and Associated Risk Factors Among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese EthnicitiesCA: A Cancer Journal for Clinicians, 2007
- Influence of Body Mass Index on Prognosis of Japanese Patients with Renal Cell CarcinomaUrology, 2007
- Impact of Body Mass Index on Survival of Patients With Surgically Treated Renal Cell CarcinomaJournal of Urology, 2006
- Effects of Excess Weight on Cancer Incidences Depending on Cancer Sites and Histologic Findings Among Men: Korea National Health Insurance Corporation StudyJournal of Clinical Oncology, 2005
- Relation of Height, Body Mass, Energy Intake, and Physical Activity to Risk of Renal Cell Carcinoma: Results from the Netherlands Cohort StudyAmerican Journal of Epidemiology, 2004
- Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patientsJournal of Surgical Oncology, 2004
- Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumorsUrology, 2004
- Obesity, Hypertension, and the Risk of Kidney Cancer in MenNew England Journal of Medicine, 2000